As the hardtsking staff has previously noted, there’s ample evidence that the fabulously wealthy Sackler family, which unleashed OxyContin on an unsuspecting American public, played a key role in the country’s current opioid crisis.
And yet . . .
As Christopher Glazek wrote in his recent Esquire piece, “By any assessment, the family’s leaders have pulled off three of the great marketing triumphs of the modern era: The first is selling OxyContin; the second is promoting the Sackler name; and the third is ensuring that, as far as the public is aware, the first and the second have nothing to do with one another.”
(To be sure graf goes here)
To be sure, the Sackler family has experienced some blowback lately, most notably from photographer Nan Goldin, a recovering opioid addict.
Whether that can outweigh the millions of dollars Purdue Pharma is spending on full-page ads in the New York Times and the Wall Street Journal is anyone’s guess.
We, however, lack faith that Purdue’s adulgences will result in any kind of reform.